Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2522]

Scientists can predict how long prostate cancer patients will respond to olaparib

Scientists can predict how long prostate cancer patients will respond to olaparib

Polyphyllin II suppresses cell migration, invasion, and metastasis by inducing cytoskeletal rearrangement through the ROCK1/LIMK/CFL1 pathway in bladder cancer cells

Polyphyllin II suppresses cell migration, invasion, and metastasis by inducing cytoskeletal rearrangement through...

New study unveils key strategies against drug-resistant prostate cancer

New study unveils key strategies against drug-resistant prostate cancer

Prostate cancer picked up earlier and cheaper in buses than GP system

Prostate cancer picked up earlier and cheaper in buses than GP system

New genetic changes linked to testicular cancer offer fresh insights into the disease and its treatment

New genetic changes linked to testicular cancer offer fresh insights into the disease and its treatment

MRI-guided radiation therapy reduces long-term side effects for patients with prostate cancer

MRI-guided radiation therapy reduces long-term side effects for patients with prostate cancer

Treatment advances and predictive biomarkers stand to improve bladder cancer care

Treatment advances and predictive biomarkers stand to improve bladder cancer care

Combination approach shows promise for treating rare, aggressive cancers

Combination approach shows promise for treating rare, aggressive cancers

Researchers discover why taking a mushroom supplement slows or prevents prostate cancer from getting worse

Researchers discover why taking a mushroom supplement slows or prevents prostate cancer from getting worse

Study identifies new approach to overcome docetaxel resistance in patients with advanced prostate cancer

Study identifies new approach to overcome docetaxel resistance in patients with advanced prostate cancer

More from ecancer